Amgen price target raised to $450 from $400 at BMO Capital
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
AMGN received an analyst target update from BMO Capital.
Target: $450
Posted price: $390.02
Analyst firm: BMO Capital
Analyst: Evan Seigerman
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.